Keyword Analysis & Research: mannkind corporation news


Keyword Analysis


Keyword Research: People who searched mannkind corporation news also searched

Frequently Asked Questions

What is the price range for MannKind Corporation (mnkd)?

MannKind Corporation (NASDAQ:MNKD) traded at $5.19 at close of the session on Tuesday, 01/24/23, made an upward move of 6.79% on its previous day’s price. Looking at the stock we see that its previous close was $4.86 and the beta (5Y monthly) reads 1.70 with the day’s price range being $4.77 – $5.2199.

What is MannKind?

Learn more about MannKind. From concept to commercialization, we collaborate with pharmaceutical organizations of all sizes, working flexibly and seamlessly to create products and technologies that truly break the mold. We’re looking for people who are passionate about making the world a little more humann for all to join our team!

What are MannKind Corporation's earnings estimates for 2023?

MannKind Corporation has a market cap of $1. 30 billion and is expected to release its quarterly earnings report on Feb 22, 2023 – Feb 27, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$0. 09, with the EPS growth for the year raised at -$0. 36 for 2022 and -$0. 13 for next year. These figures represent -12.

How did MannKind Corporation perform in the third quarter?

“In the third quarter, we grew total revenues by 48% over 2021 as our collaboration with United Therapeutics had its first full quarter during which we recognized both manufacturing revenue and royalties associated with the launch of Tyvaso DPI,” said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation.


Search Results related to mannkind corporation news on Search Engine